“Clinical Responses in Patients With Moderate-to-Severe Plaque Psoriasis Following Withdrawal and Re-Treatment With Risankizumab or Switching from Ustekinumab to Risankizumab”. SKIN The Journal of Cutaneous Medicine 1, no. 3.1 (October 27, 2017): s5. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/77.